Upload
others
View
42
Download
3
Embed Size (px)
Citation preview
©2018 Waters Corporation 1COMPANY CONFIDENTIAL
Empower Methoden Validierungs Manager MVM
Carsten Fischer
©2018 Waters Corporation 2COMPANY CONFIDENTIAL
Outline
– Introduction: regulatory perspective on method validation
o Typical validation characteristics
o Guidelines for validation
o Challenges with method validation
– Overview of method validation with Empower MVM
– Validation protocol using Empower MVM
– Validation Study using Empower MVM
©2018 Waters Corporation 3COMPANY CONFIDENTIAL
Empower Methoden Validierungs Manager MVM
Carsten Fischer
©2018 Waters Corporation 4COMPANY CONFIDENTIAL
Pharmaceutical DevelopmentBackground
API or drug
substance
Binding materials, dyes,
preservatives, flavoring
agents
Inactive
Ingredients
+Finished Drug
Products
Each NDA and ANDA must include analytical procedures necessary to ensure the identity, strength,quality, purity and potency of the drug substance and drug product. Each BLA must include a fulldescription of the manufacturing process, including analytical procedures that demonstrate themanufactured product meets prescribed standards of identity, quality, safety, purity, and potency.
FDA CDER, Analytical Procedures and Method Validation for Drugs and Biologics, Guidance for Industry, July 2015
©2018 Waters Corporation 5COMPANY CONFIDENTIAL
Regulatory Perspective on Method ValidationGuidelines
ICH: ICH Q2, Validation of Analytical Procedures, International Conference on Harmonization, November 1996
USP: USP General Chapter, <1225>, Validation of Compendia Procedures, The United States Pharmacopeia Convention, official May 1, 2013
FDA: CDER, Validation of Chromatographic Methods, Center for Drug Evaluation and Research, November 1994and Analytical Procedures and Method Validation for Drugs and Biologics, Guidance for Industry, July 2015
ISO 5725-1/-2/-3/-4/-6 and ISO/IEC 17025: STSTP : Validation des procédures analytiques quantitatives : Harmonisation des démarches” Partie I -Generalites :
STP Pharma Prat., 7, 101-138, 2003, Partie II –Statistiques : STP Pharma Prat., 16, 31-60, 2006 and Partie III –Exemples : STP Pharma Prat., 16, 87-122, 2006
European Medicines Agency: EMEA/CHMP/EWP/192217/2009 Rev. 1 Corr. 2 (2012)
OMCL Network of the Council of Europe: PA/PH/OMCL (13) 82 2R (2014)
©2018 Waters Corporation 6COMPANY CONFIDENTIAL
FDA Guidance for Industry: Analytical Procedures and Methods Validation for Drugs and Biologics
©2018 Waters Corporation 8COMPANY CONFIDENTIAL
Data Elements Required for ValidationUSP <1225> Requirements
Category 1: Assay for API contentCategory 2: Quantitative and limit tests for impuritiesCategory 3: Dissolution & drug release testsCategory 4: Identification tests
For each category different analytical information is neededAnalytical
Performance Characteristics
Category ICategory II
Category III Category IVQuantitative Limit Test
Accuracy Yes Yes * * NoPrecision Yes Yes No Yes NoSpecificity Yes Yes Yes * YesDetection Limit No No Yes * NoQuantitation Limit No Yes No * NoLinearity Yes Yes No * NoRange Yes Yes * * No* May be required, depending on the nature of the specific test.
©2018 Waters Corporation 9COMPANY CONFIDENTIAL
Validation Assay of API
Specificity ⚫ Demonstrate that the assay result is unaffected by the presence of impurities or excipientsby spiking drug substance or drug product with appropriate levels of these materials
Linearity
⚫ Minimum of 5 concentrations ranging from 80 to 120% of the test concentration⚫ Calculate
―Correlation coefficient―Y-intercept―Slope of the regression―Residual sum of squares
Accuracy
⚫ For a drug substance, compare test results to the reference standard & calculate recovery⚫ For a formulated product, spike drug product components or drug product with known
amounts of analyte & calculate recovery⚫ 3 levels: 80, 100 & 120%, in triplicates
Precision - Repeatability ⚫ Minimum of six determinations at 100% of the test concentration
Intermediate Precision (Ruggedness) ⚫ Compare 6 test results acquired by different analysts, on different days & different systems
General Guidelines for API Assay ProceduresUSP <1225>
©2018 Waters Corporation 10COMPANY CONFIDENTIAL
Validation Impurities Method
Specificity ⚫ Demonstrate that impurities can be separated & determined with appropriate accuracy & precision by spiking drug substance or drug product with appropriate levels
Linearity
⚫ Minimum of 5 concentrations ranging from reporting threshold level to 120% of the acceptance criteria
⚫ Calculate―Correlation coefficient―Y-intercept―Slope of the regression―Residual sum of squares
Accuracy
Accuracy should be assessed using drug substance or drug product spiked with known amount of impurities⚫ 3 levels ranging from reporting level to 120% of the specification, in triplicates⚫ Calculate % Recovery
Precision - Repeatability ⚫Minimum of 6 determinations
Intermediate Precision (Ruggedness) ⚫ Compare 6 test results acquired by different analysts, on different days & different systems
General Guidelines for Validation of Impurities ProceduresUSP <1225>
©2018 Waters Corporation 12COMPANY CONFIDENTIAL
Some Challenges with Validation of Chromatographic Methods
Lack of guidelines Incomplete validation procedure Missing validation criteria
Incomplete Validation SOP’s
Lack of adherence to the validation specifications
Results not consistently calculated
Lab deviations & procedure modifications not recorded
Lack of approval signatures
Incorrect Data Collection & Processing
No retention & traceability of data
Inadequate document control policies
Lack of usernames or passwords
Poor security control over lab electronic data
Poor Documentation Practices
©2018 Waters Corporation 15COMPANY CONFIDENTIAL
Increase Efficiency of Method Validation✓Create, store & approve validation protocols for different method
types & products
✓Execute the entire validation study in one Empower project
Instrument set up, data acquisition, reviewing, approval & reporting
Statistical calculations
✓Perform Design of Experiments (DoE) for Method Robustness & Intermediate Precision
✓Ensure compliance
Check status of each step against validation requirements
Flag out-of-specification (OOS) results
Secure data storage & traceability
Sign off via electronic signatures
Method Validation with Empower ® MVM
©2018 Waters Corporation 16COMPANY CONFIDENTIAL
Method Validation Workflow with Empower MVM▪ Define validation requirements
‒ Validation tests & acceptance criteria‒ Sample set for each test‒ System precision‒ Approval requirements
▪ Manage study in one project‒ Data acquisition, review & processing‒ Statistical calculations‒ Results review & approval‒ Compliance of ongoing tests against requirements
▪ Validation report templates▪ Customize reports as needed▪ Electronic signatures
Protocol
Validation Study
Reporting
©2018 Waters Corporation 17COMPANY CONFIDENTIAL
Empower MVM License
Activate license for Empower MVM
©2018 Waters Corporation 18COMPANY CONFIDENTIAL
Validation Report 11
Workflow
Injection Channel 1 Result 11 Report 111
Report 112
Result 12
Report 121
Report 122
Channel 2
Method Set
Temp = 40ºCFlow = 1 ml/minLambda =273 nmVial = 1 Volume = 15 ul
Instrumentmethod
Threshold = 2Peak width = 25RT cafeine = 0.9 min
A4MarginsGraphics and tables
Processingmethod
ReportMethod
ID1010ID1003
ID1001ID1002
ID1004
ID1005
ID1006
ID1007
ID1009
ID1008
ID2010
ValidationProtocolMethod
Validation Tests: Specificity, Linearity (5 levels), IntermediatePrecision (Analyst, Column, etc.)
Acceptance criteria:RSD% ≤ 2,0 %,
R ≥ 0,996
Validation Result 11
ID2013
Result 21
ValidationStudy
©2018 Waters Corporation 19COMPANY CONFIDENTIAL
Empower Validation Project Types
Validation Project Types
▪ Validation Template – create & store validation protocols
▪ Validation Working – validation study‒ Acquire data‒ Review & process ‒ Compare results against validation criteria
(process validation)‒ Create validation reports‒ Sign off electronically
©2018 Waters Corporation 20COMPANY CONFIDENTIAL
Empower Validation ProjectExample of Empower MVM project
Sample Set Method (SSM)
Sample Set (SS)
Result Set (RS)
Run
Validate
Sign-off
Process
Signed-of Result Set
Validation Results (VR)
Validation Study
©2018 Waters Corporation 21COMPANY CONFIDENTIAL
Workflow for Method Validation Study with Empower MVM Project Type: Validation Working
Yes
Complete all validation tests
Process validation data & attach validation result ID
Process chromatographic data & attach result set ID
Run sample set to collect data for each validation test & attach sample set ID
Create validation study using previously created validation protocol methodAdd or modify validation tests & attach sample set method to each test if needed
Validation Study Complete
No
Study approval required? Approve
Note: Approve each step of validation if Approvals/Sign Offs are required
©2018 Waters Corporation 22COMPANY CONFIDENTIAL
Validation Protocol for Impurity MethodCase Study
Imp.
F
API
Imp.
A Imp.
G
Imp.
9
Imp.
HIm
p. C
Imp.
D
Imp.
BAU
0.00
0.02
0.04
Minutes1.10 1.65 2.20 2.75 3.30 3.85 4.40
Processing method: select component type for each peak
Goal: validate a UPLC method for Metoclopramide API & related compounds
©2018 Waters Corporation 23COMPANY CONFIDENTIAL
Method Validation Protocol Empower MVM
▪ Define validation requirements‒ Validation tests & acceptance criteria‒ Sample set for each test‒ System precision‒ Approval requirements
Protocol
©2018 Waters Corporation 24COMPANY CONFIDENTIAL
Creating Validation Protocol Project Type: Validation Template
©2018 Waters Corporation 25COMPANY CONFIDENTIAL
Workflow for Creating Validation Protocol Method Project Type: Validation Template
Identify ▪ Compound Type▪ Analytical Method Type▪ Development Phase▪ Protocol Comments
Specify Validation Test
Create Validation Protocol
Method
Define▪ Acquisition Parameters (required)▪ Processing Parameters (required)▪ Acceptance Criteria (optional)▪ Sample Set Method (optional)
Add Validation Test?
YesNoSystem Precision Required?
Approval(s)/Signoff(s)required?
No
Skip System Precision tab
Yes
No
Skip Approval/ Signoff tab
YesSave Validation Protocol
Validation ProtocolMethod Complete
©2018 Waters Corporation 27COMPANY CONFIDENTIAL
Method ClassificationValidation Protocol1. Select compound type
2. Select analytical method type
3. Select development phase
©2018 Waters Corporation 28COMPANY CONFIDENTIAL
Validation TestsValidation Protocol
Typical validation characteristics
©2018 Waters Corporation 29COMPANY CONFIDENTIAL
Validation Test Parameters for Linearity Validation Protocol
Example 1: Linearity Test
©2018 Waters Corporation 30COMPANY CONFIDENTIAL
Validation Test Parameters for Linearity Validation Protocol (continued)
Example 1: Linearity Test
Enter• Criteria• Levels• # of preparations• # of injections per prep.
Need total of 21 injections!
7 levels
©2018 Waters Corporation 31COMPANY CONFIDENTIAL
Validation Test Parameters for Linearity Validation Protocol (continued)
Complete data acquisition requirement for linearity
©2018 Waters Corporation 32COMPANY CONFIDENTIAL
Linearity: Processing and Acceptance CriteriaValidation Protocol
Processing & Acceptance Criteria
for Linearity
©2018 Waters Corporation 33COMPANY CONFIDENTIAL
Linearity: Processing and Acceptance CriteriaSelection of Validation Target Response Factor & RRF Formula
©2018 Waters Corporation 34COMPANY CONFIDENTIAL
Linearity: Acceptance Criteria for Component TypeSet Acceptance Criteria for Components
Component Types same as in processing method
Select component type, channel, matrix, significance level
©2018 Waters Corporation 35COMPANY CONFIDENTIAL
Linearity: Acceptance Criteria for Component Type (continued)
Target RF Source
FitWeighting
Average by
©2018 Waters Corporation 36COMPANY CONFIDENTIAL
Select Criteria Table
Linearity: Relative Acceptance Criteria
©2018 Waters Corporation 38COMPANY CONFIDENTIAL
Linearity: advanced conditional programming
LT(ROUND(@Vr:Assessed Field Mean,-3),0.01)*(@Vr:Assessed Field % RSD) LTE 30,0 with precision of 1
©2018 Waters Corporation 39COMPANY CONFIDENTIAL
Acceptance Criteriafor UPLC method
Acceptance Criteria Per Component
Linearity: Acceptance Criteria per ComponentUPLC Method
©2018 Waters Corporation 40COMPANY CONFIDENTIAL
Acceptance Criteria Per Component Type per Level
Define criteria for specific level if needed
Linearity: Criteria per Component Type per Level
©2018 Waters Corporation 41COMPANY CONFIDENTIAL
Create Sample Set Method for LinearityValidation Protocol
▪ Create a sample set method to meet the validation test acquisition requirement (total of 21 injections)
▪ Then, attach a Linearity sample set method
Attach Sample Set
©2018 Waters Corporation 42COMPANY CONFIDENTIAL
▪ Display ‘linearity column’ ▪ Select injections specific for
linearity▪ Levels, # of injections &
preparation must match validation requirements
▪ Total of 21 injections are needed for linearity
Sample Set Method for Linearity
©2018 Waters Corporation 43COMPANY CONFIDENTIAL
Linearity with Test Parameters and Sample Set Validation Protocol
‘SSM Status’ meets requirements ‘SSM Status’ X does not meet requirements
Attach sample set
method
Sample set method must match the acquisition requirement
©2018 Waters Corporation 44COMPANY CONFIDENTIAL
Accuracy TestValidation Protocol
Example 2: Accuracy Test
Select ‘Accuracy’ from validation list &
enter test parameters
©2018 Waters Corporation 45COMPANY CONFIDENTIAL
Accuracy: Acquisition Parameters Validation Protocol
Acquisition▪ 3 levels▪ 3 preps & 1 injection/prep▪ Total of 9 injections
©2018 Waters Corporation 46COMPANY CONFIDENTIAL
Accuracy: Processing and Acceptance CriteriaAssessed Fields
Select parameter or field to be assessed for recovery
©2018 Waters Corporation 47COMPANY CONFIDENTIAL
Accuracy: Processing and Acceptance Criteria
Acceptance Criteria▪ %Rec: 90 – 100%▪ %RSD: < 10%
©2018 Waters Corporation 48COMPANY CONFIDENTIAL
Intermediate Precision: 2 AnalystsProtocol
Example 3: Intermediate Precision for 2 analysts
2 analysts using 2 different systems
©2018 Waters Corporation 49COMPANY CONFIDENTIAL
Intermediate Precision for 2 Analysts: Acquisition
Acquisition▪ Experiment grouped by
analysts▪ 2 experiments
‒ Experiment 1: analyst 1‒ Experiment 2; analyst 2
▪ 6 preps per each analyst with 1 injection
▪ Total 12 injections
©2018 Waters Corporation 50COMPANY CONFIDENTIAL
Intermediate Precision for 2 Analysts: Acceptance Criteria
▪ Assessed field: Recovery
▪ Acceptance Criteria‒ %Rec: 90 – 100%‒ %RSD: < 10%
©2018 Waters Corporation 51COMPANY CONFIDENTIAL
Intermediate Precision for 2 AnalystsSample Sets
Need 2 sample set methods
Total of 12 injections: 6 preps by Analyst A & 6 by Analyst B
Analyst A Analyst B
©2018 Waters Corporation 52COMPANY CONFIDENTIAL
Intermediate Precision for 2 AnalystsAttaching Sample Sets
Attach Sample Set MethodsMUST have 2 sample set methods ▪ Data acquired by Analyst 1▪ Data acquired by Analyst 2
Error for only one sample set
©2018 Waters Corporation 53COMPANY CONFIDENTIAL
Robustness Validation Protocol
Robustness
Example 4: Robustness
©2018 Waters Corporation 54COMPANY CONFIDENTIAL
Robustness: Acquisition Validation Protocol
Acquisition • Define # of factors
o column temp.o flow rateo wavelengths
• 2 levels/Factor• 5 center points preps
2 Experimental Designs• Full & ½ factorial
Method ConditionsColum temp. 45°CFlow rate 0.60 mL/minWavelength 270 nm
©2018 Waters Corporation 55COMPANY CONFIDENTIAL
Robustness: Full Factorial Experiment DesignValidation Protocol
Full Factorial 8 experiments with combination of: • column temp.• flow rate• wavelengths
Method ConditionsColum temp. 45°CFlow rate 0.60 mL/minWavelength 270 nm
©2018 Waters Corporation 56COMPANY CONFIDENTIAL
Create Sample Set Method with Empower® Sample Set Generator
Open MVM Robustness Test
View Factors in Sample Set Generator
“Map” factors to instrument or sequence parameters
Select blank & System Suit Strategy
Click “Generate”
Sample Sets & Method Sets Created
©2018 Waters Corporation 57COMPANY CONFIDENTIAL
Robustness Sample Set for Full Factorial Created using a Sample Set Generator
Full Factorial 8 experiments with combination of:• column temp.• flow rate• wavelengths
Method ConditionsColum temp. 45°CFlow rate 0.60 mL/minWavelength 270 nm
©2018 Waters Corporation 58COMPANY CONFIDENTIAL
Robustness Partial Factorial Experiment DesignValidation Protocol
1/2 Factorial4 experiments with combination of: • column temp.• flow rate• wavelengths
Method ConditionsColum temp. 45°CFlow rate 0.60 mL/minWavelength 270 nm
©2018 Waters Corporation 59COMPANY CONFIDENTIAL
Robustness: Processing and Acceptance CriteriaValidation Protocol
Criteria to assess the USP Rs
USP Rs ≥ 2.0
©2018 Waters Corporation 60COMPANY CONFIDENTIAL
Validation Protocol Example Project Type: Validation Template
Validation protocols are customizable
Typical Validation Characteristics
©2018 Waters Corporation 61COMPANY CONFIDENTIAL
Efficient Sample Sets to Reduce Analysis TimeValidation Protocol
ONE sample set for multiple validation tests▪ Select injections for each
test
©2018 Waters Corporation 62COMPANY CONFIDENTIAL
System Precision RequirementsValidation Protocol
System suitability criteria
©2018 Waters Corporation 63COMPANY CONFIDENTIAL
Approval Requirements Validation Protocol
Approval requirements for different steps
©2018 Waters Corporation 64COMPANY CONFIDENTIAL
Approvals/Sign OffsValidation Protocol
Enter username/password
Approve or Disapprove Protocol Method
©2018 Waters Corporation 65COMPANY CONFIDENTIAL
Summary
Organized & completed validation protocol is critical to a successful validation
Validation protocol with Empower MVM– Validation test with data acquisition & acceptance criteria requirements– Create sample set methods – MVM checks sample set methods for adherence to the acquisition requirements
& flags any errors– Electronic approval– Improves compliance!!!
©2018 Waters Corporation 66COMPANY CONFIDENTIAL
Validation Study Example Project Type: Validation Working
✓Each validation step checked for adherence to the requirements
✓OOS results flagged
✓Unique IDs assigned for data traceability
✓Electronic Sign Off(s)
©2018 Waters Corporation 67COMPANY CONFIDENTIAL
Conclusions
Empower MVM Software
Improve compliance
Integrate protocols & specifications Monitor status of ongoing tests Review & approve data via electronic signatures Monitor audit trails & user privileges
Increase efficiency Manage the entire study in one place Automated & customizable reporting
Reduce errors Perform statistical calculations No more spreadsheets or additional software
Confidence Adherence to the validation requirements Eliminate transcription errors No more security concerns
©2018 Waters Corporation 68COMPANY CONFIDENTIAL
References– ICH Q2B, Validation of Analytical Procedures, International Conference on Harmonization, November 1996. – USP General Chapter, <1225>, Validation of Compendial Procedures, The United States Pharmacopeia Convention,
official May 1, 2013. – US FDA, Analytical Procedures and Methods Validation for Drugs and Biologics: Guidance for Industry, July 2015– Maziarz M., McCarthy S.M., Wrona M., Increasing Efficiency of Method Validation for Metoclopramide HCl and Related
Substances with Method Validation Manager Software, Application Note [2014], Part Number 720005111EN
Consultation Services – Please contact Ilse Hoes ([email protected])
Resources